Cargando…

Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemia

Relapse in pediatric T-cell acute lymphoblastic leukemia (T-ALL) remains a significant clinical problem and is thought to be associated with clonal selection during treatment. In this study we used an established pre-clinical model of induction therapy to increase our understanding of the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yadav, Babasaheb D., Samuels, Amy L., Wells, Julia E., Sutton, Rosemary, Venn, Nicola C., Bendak, Katerina, Anderson, Denise, Marshall, Glenn M., Cole, Catherine H., Beesley, Alex H., Kees, Ursula R., Lock, Richard B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Priority Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312271/ https://www.ncbi.nlm.nih.gov/pubmed/27623214 http://dx.doi.org/10.18632/oncotarget.11233

Ejemplares similares

Examining treatment responses of diagnostic marrow in murine xenografts to predict relapse in children with acute lymphoblastic leukaemia
por: Alruwetei, Abdulmohsen M., et al.
Publicado: (2020)

A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia
por: Samuels, A L, et al.
Publicado: (2014)

Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia
por: Beesley, Alex H, et al.
Publicado: (2010)

Validation of a mouse xenograft model system for gene expression analysis of human acute lymphoblastic leukaemia
por: Samuels, Amy L, et al.
Publicado: (2010)

Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia
por: Cerny-Reiterer, Sabine, et al.
Publicado: (2014)

BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemia
por: Li, Yulin, et al.
Publicado: (2016)

Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model
por: Hasan, Md. Nabiul, et al.
Publicado: (2014)

Inhibition of the NEDD8 conjugation pathway induces calcium-dependent compensatory activation of the pro-survival MEK/ERK pathway in acute lymphoblastic leukemia
por: Zheng, Shuhua, et al.
Publicado: (2017)

Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples
por: Opota, Onya, et al.
Publicado: (2020)

The evolution of clinical trials for infant acute lymphoblastic leukemia
por: Kotecha, R S, et al.
Publicado: (2014)

Improving the Identification of High Risk Precursor B Acute Lymphoblastic Leukemia Patients with Earlier Quantification of Minimal Residual Disease
por: Karsa, Mawar, et al.
Publicado: (2013)

Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity
por: Ketola, Kirsi, et al.
Publicado: (2021)

Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study
por: Cleaver, Amanda L, et al.
Publicado: (2010)

Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy
por: Sandri, Sara, et al.
Publicado: (2017)

COBL is a novel hotspot for IKZF1 deletions in childhood acute lymphoblastic leukemia
por: Lopes, Bruno Almeida, et al.
Publicado: (2016)

Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions
por: Valent, Peter, et al.
Publicado: (2017)

Hypophosphatemia Due to Increased Effector Cell Metabolic Activity Is Associated with Neurotoxicity Symptoms in CD19-Targeted CAR T-cell Therapy
por: Tang, Jack Pengfei, et al.
Publicado: (2022)

MEK1 is required for the development of NRAS-driven leukemia
por: Nowacka, Joanna D., et al.
Publicado: (2016)

High intensity interval training in the heat enhances exercise-induced lipid peroxidation, but prevents protein oxidation in physically active men
por: Souza-Silva, Ana Angélica, et al.
Publicado: (2015)

Protein drug target activation homogeneity in the face of intra-tumor heterogeneity: implications for precision medicine
por: Parasido, Erika Maria, et al.
Publicado: (2016)

Defining a therapeutic window for kinase inhibitors in leukemia to avoid neutropenia
por: McArthur, Kate, et al.
Publicado: (2017)

A Mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy
por: Bryant, Kelly G., et al.
Publicado: (2017)

Upregulation of long noncoding RNA MIAT in aggressive form of chronic lymphocytic leukemias
por: Sattari, Arash, et al.
Publicado: (2016)

The bone marrow microenvironment of pre-B acute lymphoblastic leukemia at single-cell resolution
por: Anderson, Denise, et al.
Publicado: (2020)

The Promise of Single-cell Technology in Providing New Insights Into the Molecular Heterogeneity and Management of Acute Lymphoblastic Leukemia
por: Pearson, Holly C.L., et al.
Publicado: (2022)

How murine models of human disease and immunity are influenced by housing temperature and mild thermal stress
por: James, Caitlin M., et al.
Publicado: (2022)

Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation
por: Lin, Shan, et al.
Publicado: (2016)

Gadd45a deficiency accelerates BCR-ABL driven chronic myelogenous leukemia
por: Mukherjee, Kaushiki, et al.
Publicado: (2017)

Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions
por: Venn, Nicola C., et al.
Publicado: (2022)

Tumor Trp53 status and genotype affect the bone marrow microenvironment in acute myeloid leukemia
por: Jacamo, Rodrigo, et al.
Publicado: (2017)

Hostility and Cellular Aging in Men from the Whitehall II Cohort
por: Brydon, Lena, et al.
Publicado: (2012)

PBRM1 Inactivation Promotes Upregulation of Human Endogenous Retroviruses in a HIF-Dependent Manner
por: Zhou, Mi, et al.
Publicado: (2022)

Niclosamide suppresses acute myeloid leukemia cell proliferation through inhibition of CREB-dependent signaling pathways
por: Chae, Hee-Don, et al.
Publicado: (2017)

MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia
por: Tagde, Ashujit, et al.
Publicado: (2016)

Transcriptional regulation of HSPB1 by Friend leukemia integration-1 factor modulates radiation and temozolomide resistance in glioblastoma
por: Rajesh, Yetirajam, et al.
Publicado: (2020)

Loss of p53-inducible long non-coding RNA LINC01021 increases chemosensitivity
por: Kaller, Markus, et al.
Publicado: (2017)

A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia
por: Kay, Neil E., et al.
Publicado: (2016)

Carbonic anhydrase IX induction defines a heterogeneous cancer cell response to hypoxia and mediates stem cell-like properties and sensitivity to HDAC inhibition
por: Ledaki, Ioanna, et al.
Publicado: (2015)

Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34(+) proliferating and quiescent chronic myeloid leukemia blast crisis cells
por: Carter, Bing Z., et al.
Publicado: (2015)

Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors
por: Liu, Qinghai, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2fa62ir1s617kcgaumjkq56fqe